Eton Pharma falls after fourth-quarter loss
ReutersMar 18, 2025 5:17 PM
Drug developer Eton Pharmaceuticals' ETON.O shares fall 2.2% to $13.39
Company posts fourth-quarter net loss of 2 cents per share vs analysts' estimate of break even per share, according to data compiled by LSEG
Company reports product revenue of $11.65 million vs est $10.53 million
As of last close, Eton Pharma's shares have more than tripled in the past 12 months
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
After $20B Debt Sale, Google’s Rare 100-Year Bond Sparks Scrutiny: Has AI Drained the Tech Giant’s Coffers?
TradingKey - According to a Financial Times report, Google parent Alphabet (GOOG)(GOOGL) is planning to issue bonds denominated in British pounds and Swiss francs, which may include the first 100-year GBP bond of this century.TradingKey
10 hours ago
Investing in Health Stock: Will GLP-1 Pill Copycat Restrictions Derail Hims & Hers? Is HIMS Still a Good Choice in 2026?
Hims & Hers' subscription-based business model, coupled with tailored treatment regimens, allows users to maintain lasting engagement, a critical aspect of the company’s growth narrative and a reason why some see Hims & Hers stock as a play on long-term digital health as opposed to a traditional phaTradingKey
13 hours ago
SpaceX IPO Approaching: Will EchoStar Be a Good Buy in 2026?
TradingKey - Today, EchoStar (SATS) is a hybrid story around legacy consumer communications and a high-profile private space play. As a result of its merger with DISH, the company offers satellite TV services and the wireless brand Boost Mobile, in addition to spectrum assets and wholesale network aTradingKey
16 hours ago
Market Cap Erased, Successive Downgrades? Wall Street Is Re-evaluating Microsoft’s AI Future
TradingKey - In early 2026, tech giant Microsoft (MSFT) got off to a less-than-ideal start. Year-to-date, its share price has fallen by more than 12%, and its total market capitalization briefly dipped below the $3 trillion mark. As a former leader in technological innovation, why has Microsoft suddenly appeared to stumble in the current AI wave? What are the underlying issues?TradingKey
19 hours ago
